CDKN2A and neoplasm: Given the high agreement between p16-IHC and HPV-DNA results in the subset of samples tested, and the recommendation of this test as a surrogate marker for HPV-positivity on a clinical setting41, we considered patients with tumor p16-IHC expression as positive for HPV infection in this study.